Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1897 1
1898 1
1928 2
1934 1
1935 1
1938 1
1940 1
1945 30
1946 88
1947 97
1948 118
1949 119
1950 130
1951 207
1952 213
1953 230
1954 234
1955 253
1956 206
1957 254
1958 237
1959 225
1960 256
1961 304
1962 301
1963 457
1964 570
1965 361
1966 363
1967 441
1968 443
1969 504
1970 466
1971 533
1972 511
1973 467
1974 527
1975 546
1976 525
1977 550
1978 580
1979 687
1980 631
1981 766
1982 820
1983 900
1984 1032
1985 1143
1986 1086
1987 1126
1988 1205
1989 1458
1990 1496
1991 1344
1992 1563
1993 1811
1994 1847
1995 1814
1996 1881
1997 1957
1998 1985
1999 2104
2000 2242
2001 2367
2002 2383
2003 2656
2004 2880
2005 3015
2006 3325
2007 3449
2008 3510
2009 3846
2010 4075
2011 4445
2012 4805
2013 4978
2014 5390
2015 5707
2016 5788
2017 5781
2018 5865
2019 6424
2020 7214
2021 7502
2022 7203
2023 6814
2024 7141
2025 7883
2026 3791

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157,355 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian Cancer Immunotherapy and Personalized Medicine.
Morand S, Devanaboyina M, Staats H, Stanbery L, Nemunaitis J. Morand S, et al. Int J Mol Sci. 2021 Jun 18;22(12):6532. doi: 10.3390/ijms22126532. Int J Mol Sci. 2021. PMID: 34207103 Free PMC article. Review.
Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may improve the predictiveness of response to immunotherapy. ...This paper reviews the rol …
Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopula …
Ovarian Cancer: An Integrated Review.
Stewart C, Ralyea C, Lockwood S. Stewart C, et al. Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11. Semin Oncol Nurs. 2019. PMID: 30867104 Review.
CONCLUSION: There is no screening test for ovarian cancer and with diagnosis often in the late stages, recurrence is high in this population. ...Although advances are being made, ovarian cancer remains the most fatal female gynecologic cancer. I …
CONCLUSION: There is no screening test for ovarian cancer and with diagnosis often in the late stages, recurrence is high in t …
Ovarian Cancer-Epidemiology, Classification, Pathogenesis, Treatment, and Estrogen Receptors' Molecular Backgrounds.
Smolarz B, Biernacka K, Łukasiewicz H, Samulak D, Piekarska E, Romanowicz H, Makowska M. Smolarz B, et al. Int J Mol Sci. 2025 May 12;26(10):4611. doi: 10.3390/ijms26104611. Int J Mol Sci. 2025. PMID: 40429755 Free PMC article. Review.
Global epidemiological reports indicate a steady increase in the tendency to develop ovarian cancer. The symptoms of ovarian cancer are non-specific, and there is no effective screening tool. Most often, surgery, chemotherapy, and radiotherapy, alone o …
Global epidemiological reports indicate a steady increase in the tendency to develop ovarian cancer. The symptoms of ovaria …
Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Zhang M, et al. Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188503. doi: 10.1016/j.bbcan.2021.188503. Epub 2021 Jan 7. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33421585 Review.
After it was discovered approximately 40 years ago, carbohydrate antigen 125 (CA125) became the most widely used and concerning biomarker in ovarian cancer screening. However, there is still controversy about its role in clinical practice. CA125 is not sufficiently …
After it was discovered approximately 40 years ago, carbohydrate antigen 125 (CA125) became the most widely used and concerning biomarker in …
Clinical Staging of Ovarian Cancer.
O'Shea AS. O'Shea AS. Methods Mol Biol. 2022;2424:3-10. doi: 10.1007/978-1-0716-1956-8_1. Methods Mol Biol. 2022. PMID: 34918284
The clinical management and prognosis of ovarian cancer depend upon the stage of the cancer. Cancer stage is the extent to which the cancer has spread from its site of origin. ...In more advanced cases, this surgery may also include procedures t …
The clinical management and prognosis of ovarian cancer depend upon the stage of the cancer. Cancer stage is the …
Ovarian Cancer: An Overview.
Penny SM. Penny SM. Radiol Technol. 2020 Jul;91(6):561-575. Radiol Technol. 2020. PMID: 32606233 Review.
Ovarian cancer currently is the fifth leading cause of cancer-related deaths among women in the United States, and approximately 140 000 women die globally per year of ovarian cancer. ...To provide care that is most favorable for the patient, he …
Ovarian cancer currently is the fifth leading cause of cancer-related deaths among women in the United States, and appr …
Ovarian Cancer: A Heterogeneous Disease.
Kossaï M, Leary A, Scoazec JY, Genestie C. Kossaï M, et al. Pathobiology. 2018;85(1-2):41-49. doi: 10.1159/000479006. Epub 2017 Oct 12. Pathobiology. 2018. PMID: 29020678
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes, these are treated as a single disease. Tremendous efforts have …
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and progn …
Ovarian cancer in pregnancy.
Jorgensen JR, Brewer MA, Runowicz CD. Jorgensen JR, et al. Semin Perinatol. 2025 Mar;49(2):152043. doi: 10.1016/j.semperi.2025.152043. Epub 2025 Mar 13. Semin Perinatol. 2025. PMID: 40089322 Review.
OBJECTIVE: The objective of this manuscript is to review the epidemiology, diagnosis, treatment and outcomes of ovarian cancers diagnosed during pregnancy. FINDING: Ovarian cancer in pregnancy, although rare, is more likely to be diagnosed early during pregna …
OBJECTIVE: The objective of this manuscript is to review the epidemiology, diagnosis, treatment and outcomes of ovarian cancers diagn …
LncRNAs in ovarian cancer.
Wang JY, Lu AQ, Chen LJ. Wang JY, et al. Clin Chim Acta. 2019 Mar;490:17-27. doi: 10.1016/j.cca.2018.12.013. Epub 2018 Dec 13. Clin Chim Acta. 2019. PMID: 30553863 Review.
Ovarian cancer is one of the most common gynecologic malignancies and has a poor prognosis. ...Finally, we provide insight into the potential of lncRNAs for evaluating the diagnosis and prognosis of ovarian cancer....
Ovarian cancer is one of the most common gynecologic malignancies and has a poor prognosis. ...Finally, we provide insight int …
Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
Benedetti Panici P, Giannini A, Fischetti M, Lecce F, Di Donato V. Benedetti Panici P, et al. Curr Oncol Rep. 2020 Feb 8;22(3):22. doi: 10.1007/s11912-020-0883-2. Curr Oncol Rep. 2020. PMID: 32036457 Review.
PURPOSE OF REVIEW: The aim of this review is to determine, in the light of recent evidences, the role of lymphadenectomy in ovarian cancer. RECENT FINDINGS: The lymphadenectomy in ovarian neoplasms (LION) trial reports no better outcomes and higher com …
PURPOSE OF REVIEW: The aim of this review is to determine, in the light of recent evidences, the role of lymphadenectomy in ovarian …
157,355 results
You have reached the last available page of results. Please see the User Guide for more information.